ATE96662T1 - Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen. - Google Patents

Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.

Info

Publication number
ATE96662T1
ATE96662T1 AT90907580T AT90907580T ATE96662T1 AT E96662 T1 ATE96662 T1 AT E96662T1 AT 90907580 T AT90907580 T AT 90907580T AT 90907580 T AT90907580 T AT 90907580T AT E96662 T1 ATE96662 T1 AT E96662T1
Authority
AT
Austria
Prior art keywords
treatment
medication
manufacture
viral infections
aliphatic alcohols
Prior art date
Application number
AT90907580T
Other languages
English (en)
Inventor
David H Katz
Original Assignee
Lidak Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/345,084 external-priority patent/US4874794A/en
Application filed by Lidak Pharmaceuticals filed Critical Lidak Pharmaceuticals
Application granted granted Critical
Publication of ATE96662T1 publication Critical patent/ATE96662T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90907580T 1989-04-28 1990-04-16 Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen. ATE96662T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment
US07/431,304 US5071879A (en) 1989-04-28 1989-11-02 Systemic antiviral treatment
PCT/US1990/002046 WO1990013287A1 (en) 1989-04-28 1990-04-16 Use of c-20 to c-26 aliphatic alcohols in the treatment of viral infections

Publications (1)

Publication Number Publication Date
ATE96662T1 true ATE96662T1 (de) 1993-11-15

Family

ID=26994246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90907580T ATE96662T1 (de) 1989-04-28 1990-04-16 Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.

Country Status (8)

Country Link
US (1) US5071879A (de)
EP (1) EP0469064B1 (de)
JP (1) JP3064010B2 (de)
AT (1) ATE96662T1 (de)
DE (1) DE69004425T2 (de)
DK (1) DK0469064T3 (de)
ES (1) ES2062529T3 (de)
WO (1) WO1990013287A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
DE60020914T2 (de) 1999-09-03 2005-12-01 Cabby Business Inc., Road Town Effizientes Verfahren zur Herstellung sehr reiner Sterinen
US20030018074A1 (en) * 2001-07-06 2003-01-23 Robert Kleiman Antiviral composition and treatment method
WO2003032915A2 (en) * 2001-10-16 2003-04-24 Avanir Pharmacueticals Viral inhibition by n-docosanol
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
DE3318989C2 (de) * 1982-05-28 1996-11-21 Eisai Co Ltd ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
IT1203934B (it) * 1987-04-17 1989-02-23 Consiglio Nazionale Ricerche Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury

Also Published As

Publication number Publication date
EP0469064A1 (de) 1992-02-05
DE69004425T2 (de) 1994-02-24
ES2062529T3 (es) 1994-12-16
DK0469064T3 (da) 1994-03-21
EP0469064B1 (de) 1993-11-03
US5071879A (en) 1991-12-10
JP3064010B2 (ja) 2000-07-12
WO1990013287A1 (en) 1990-11-15
DE69004425D1 (de) 1993-12-09
JPH05501542A (ja) 1993-03-25

Similar Documents

Publication Publication Date Title
ATE121907T1 (de) Methoden zur verhinderung von schimmel.
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
HUT55951A (en) Fungicidal compositions comprising acrylic acid derivatives as active ingredient and process for producing the active ingredient
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
SE8300623L (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
JPS5645452A (en) Noxious organism repellant
ES464354A1 (es) Procedimiento de preparacion de un complejo insectifugo e insecticida estable.
ATE96662T1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
DK403187A (da) Praeparat til transdermal indgift
JPS6434909A (en) Cosmetic
MX170055B (es) , "composicion insecticida y procedimiento para su obtencion
DK0443848T3 (da) Nyt antiulcermiddel
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
DE69000719D1 (de) Hautreinigungsmittel.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
BG31062A3 (en) Insecticide means
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
TR18712A (tr) Pirikidin (4,6) - diil - bis - (tiono) (tiol) fosforik (fosfonik) asit esterleri,bunlarin hazurlanisina ait usul ve bunlarin ensektisidler ve akarisidler olarak kullanilmalari
JPS5391125A (en) Insectcides composition containing chrysanthemumic acid esters and process for their preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time